COVAXIN

AAP questions Centre for supplying Covid-19 vaccines abroad

AAP said that the government is more concerned about Prime Minister Narendra Modi’s global image than saving people’s lives.

COVAXIN has an efficacy of 81% in its Phase 3 clinical trial: Bharat Biotech

Bharat Biotech claims vaccine effective against new UK COVID strain

UN offers support as India executes worlds largest COVID-19 vaccination drive

Recipients to be followed-up for 3 months after 2nd dose of Covaxin, ICMR issues guidelines

Individuals cannot choose COVID-19 vaccine they prefer, says Health Ministry

India to begin COVID-19 vaccination drive from January 16, ‘A landmark step’ tweets PM Modi

India’s abrupt Covaxin approval draws questions over its efficacy

Bharat Biotech and Serum Institute of India will work together to eliminate Coronavirus

Private clinics of Brazil sign deal with India to get alternative COVID-19 vaccine

Government to initiate massive COVID-19 vaccine production after scientists’ approval

Haryana Minister Anil Vij tests COVID-19 positive, was given shot of Covaxin last month

Bharat Biotech’s Covaxin will be 60% effective, tentatively to launch in September 2021

Bharat Biotech to commence Phase 3 trail of COVAXIN with 26,0000 participants

No COVID-19 vaccine for common Indian till 2022

In February, a launch of the Indian vaccine, COVAXIN will be rolled out.